Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

Back

ESC Professional Premium Access

Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

Session: Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Topic: Heart Failure in Atrial Fibrillation

Speaker: Ms A. Lizancos Castro (Vigo, ES)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Ms Andrea Lizancos Castro

Hospital Universitario Alvaro Cunqueiro, Vigo (Spain)

0 follower

6 more presentations in this session

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation

Speaker: Doctor G. Moschovitis (Lugano, CH)

Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients

Speaker: Doctor U. Baumer (Vienna, AT)

Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study

Speaker: Mr C. Tsang (Hong Kong, HK)

Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization

Speaker: Mr S. Majumder (Minneapolis, US)

Impact of cardiorenal syndrome on clinical outcomes of atrial fibrillation patients undergoing catheter ablation

Speaker: Doctor H. Matsuura (Fukuoka, JP)

Access the full session

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Speakers: Ms A. Lizancos Castro, Doctor G. Moschovitis, Doctor U. Baumer, Mr C. Tsang, Mr S. Majumder...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

About the speaker

Ms Andrea Lizancos Castro

6 more presentations in this session

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation

Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients

Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study

Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization

Impact of cardiorenal syndrome on clinical outcomes of atrial fibrillation patients undergoing catheter ablation

Access the full session

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

About the event

ESC Congress 2023

ESC 365 is supported by